Genetic Polymorphisms of the CASP8 Gene Promoter May Not Be Associated with Colorectal Cancer in Han Chinese from Southwest China

PLoS ONE

Volumn 8, Issue 7, 2013, Pages

  Xiao, Mei Sheng ^a   Chang, Le ^b   Li, Wen Liang ^b   Du, Yong Sheng ^b   Pan, Yue ^b   Zhang, Deng Feng ^a,c   Wen, Yu ^b   Luo, Juan ^b   Li, Xiao Yan ^b   Yao, Yong Gang ^a  

^a KUNMING INSTITUTE OF ZOOLOGY   (China)

^b KUNMING MEDICAL UNIVERSITY   (China)

^c UNIVERSITY OF CHINESE ACADEMY OF SCIENCES   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CASPASE 8; MESSENGER RNA;

ADULT; ARTICLE; CANCER TISSUE; CASE CONTROL STUDY; CASP8 GENE; CHINESE; COLORECTAL CANCER; CONTROLLED STUDY; DNA POLYMORPHISM; FEMALE; GENE EXPRESSION; GENE FREQUENCY; GENETIC ASSOCIATION; GENETIC VARIABILITY; GENOTYPE; HAPLOTYPE; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MALE; NUCLEOTIDE SEQUENCE; PRECANCER; PROMOTER REGION; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TISSUE SECTION; WESTERN BLOTTING;

ADULT; AGED; ALLELES; ASIAN CONTINENTAL ANCESTRY GROUP; CASE-CONTROL STUDIES; CASPASE 8; COLORECTAL NEOPLASMS; FEMALE; GENE FREQUENCY; GENOTYPE; HUMANS; MALE; MIDDLE AGED; POLYMORPHISM, GENETIC; PROMOTER REGIONS, GENETIC; RNA, MESSENGER;

EID: 84879748843     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0067577     Document Type: Article

References (38)

1. Savas S, Younghusband HB, (2010) dbCPCO: a database of genetic markers tested for their predictive and prognostic value in colorectal cancer. Human Mutation 31: 901-907.
2. Cheah PY, (1990) Hypotheses for the etiology of colorectal cancer-an overview. Nutr Cancer 14: 5-13.
3. Lichtenstein P, Holm NV, Verkasalo PK, Iliadou A, Kaprio J, et al. (2000) Environmental and heritable factors in the causation of cancer-analyses of cohorts of twins from Sweden, Denmark, and Finland. N Engl J Med 343: 78-85.
4. Tsong WH, Koh W-P, Yuan J-M, Wang R, Sun C-L, et al. (2007) Cigarettes and alcohol in relation to colorectal cancer: the Singapore Chinese Health Study. Br J Cancer 96: 821-827.
5. Hoshiyama Y, Sekine T, Sasaba T, (1993) A case-control study of colorectal cancer and its relation to diet, cigarettes, and alcohol consumption in Saitama Prefecture, Japan. Tohoku J Exp Med 171: 153-165.
6. Huxley RR, Ansary-Moghaddam A, Clifton P, Czernichow S, Parr CL, et al. (2009) The impact of dietary and lifestyle risk factors on risk of colorectal cancer: a quantitative overview of the epidemiological evidence. Int J Cancer 125: 171-180.
7. Raff M, (1998) Cell suicide for beginners. Nature 396: 119-122.
8. Thompson CB, (1995) Apoptosis in the pathogenesis and treatment of disease. Science 267: 1456-1462.
9. Chen M, Wang J, (2002) Initiator caspases in apoptosis signaling pathways. Apoptosis 7: 313-319.
10. Nuñez G, Benedict MA, Hu Y, Inohara N, (1998) Caspases: the proteases of the apoptotic pathway. Oncogene 17: 3237-3245.
11. Hengartner MO, (2000) The biochemistry of apoptosis. Nature 407: 770-776.
12. Nicholson DW, Thornberry NA, (1997) Caspases: killer proteases. Trends Biochem Sci 22: 299-306.
13. Li H, Zhu H, Xu CJ, Yuan J, (1998) Cleavage of BID by caspase 8 mediates the mitochondrial damage in the Fas pathway of apoptosis. Cell 94: 491-501.
14. Sun T, Gao Y, Tan W, Ma S, Shi Y, et al. (2007) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with susceptibility to multiple cancers. Nature Genetics 39: 605-613.
15. Ni C, Ye Y, Wang M, Qian H, Song Z, et al. (2009) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter is associated with risk of coal workers' pneumoconiosis. J Toxicol Environ Health A 72: 712-716.
16. Wang M, Zhang Z, Tian Y, Shao J, (2009) A six-nucleotide insertion-deletion polymorphism in the CASP8 promoter associated with risk and progression of bladder cancer. Clin Cancer Res 15: 2567-2572.
17. Frank B, Rigas SH, Bermejo JL, Wiestler M, Wagner K, et al. (2008) The CASP8-652 6N del promoter polymorphism and breast cancer risk: a multicenter study. Breast Cancer Res Treat 111: 139-144.
18. Haiman CA, Garcia RR, Kolonel LN, Henderson BE, Wu AH, et al. (2008) A promoter polymorphism in the CASP8 gene is not associated with cancer risk. Nature Genetics 40: 259-260; author reply 260-261.
19. Lan Q, Morton LM, Armstrong B, Hartge P, Menashe I, et al. (2009) Genetic variation in caspase genes and risk of non-Hodgkin lymphoma: a pooled analysis of 3 population-based case-control studies. Blood 114: 264-267.
20. Xiao M-S, Zhang D-F, Zeng Y, Cheng Y-F, Yao Y-G, (2011) Polymorphisms in the promoter region of the CASP8 gene are not associated with non-Hodgkin's lymphoma in Chinese patients. Ann Hematol 90: 1137-1144.
21. Edge SB, Byrd DR, Compton CC, Fritz AG, Greene FL, et al. (2010) AJCC Cancer Staging Handbook.
22. Gauderman WJ, (2002) Sample size requirements for matched case-control studies of gene-environment interaction. Stat Med 21: 35-50.
23. Barrett JC, Fry B, Maller J, Daly MJ, (2005) Haploview: analysis and visualization of LD and haplotype maps. Bioinformatics 21: 263-265.
24. Stephens M, Donnelly P, (2003) A comparison of bayesian methods for haplotype reconstruction from population genotype data. Am J Hum Genet 73: 1162-1169.
25. Yao Y-G, Yang HS, Cao Z, Danielsson J, Duh EJ, (2005) Upregulation of placental growth factor by vascular endothelial growth factor via a post-transcriptional mechanism. FEBS Lett 579: 1227-1234.
26. Kantari C, Walczak H, (2011) Caspase-8 and Bid: Caught in the act between death receptors and mitochondria. Biochimica et Biophysica Acta (BBA)- Molecular Cell Research 1813: 558-563.
27. Jin ZY, El-Deiry WS, (2005) Overview of cell death signaling pathways. Cancer Biology & Therapy 4: 139-163.
28. De Vecchi G, Verderio P, Pizzamiglio S, Manoukian S, Barile M, et al. (2009) Evidences for association of the CASP8-652 6N del promoter polymorphism with age at diagnosis in familial breast cancer cases. Breast Cancer Research and Treatment 113: 607-608.
29. Lan Q, Zheng T, Chanock S, Zhang Y, Shen M, et al. (2007) Genetic variants in caspase genes and susceptibility to non-Hodgkin lymphoma. Carcinogenesis 28: 823-827.
30. Pittman AM, Broderick P, Sullivan K, Fielding S, Webb E, et al. (2008) CASP8 variants D302H and-652 6N ins/del do not influence the risk of colorectal cancer in the United Kingdom population. Br J Cancer 98: 1434-1436.
31. Gangwar R, Mandhani A, Mittal RD, (2009) Caspase 9 and caspase 8 gene polymorphisms and susceptibility to bladder cancer in north Indian population. Ann Surg Oncol 16: 2028-2034.
32. Umar M, Upadhyay R, Kumar S, Ghoshal UC, Mittal B, (2011) CASP8-652 6N del and CASP8 IVS12-19G>A gene polymorphisms and susceptibility/prognosis of ESCC: a case control study in northern Indian population. J Surg Oncol 103: 716-723.
33. Sun T, Gao Y, Tan W, Ma S, Shi Y, et al. (2008) Reply to" A promoter polymorphism in the CASP8 gene is not associated with cancer risk". Nature Genetics 40: 260-261.
34. Yin M, Yan J, Wei S, Wei Q, (2010) CASP8 polymorphisms contribute to cancer susceptibility: evidence from a meta-analysis of 23 publications with 55 individual studies. Carcinogenesis 31: 850-857.
35. Heijink DM, Kleibeuker JH, Jalving M, Boersma-van Ek W, Koornstra JJ, et al. (2007) Independent induction of caspase-8 and cFLIP expression during colorectal carcinogenesis in sporadic and HNPCC adenomas and carcinomas. Cell Oncol 29: 409-419.
36. Pan YF, Zhang MW, Jin MJ, Zhang SC, Chen K, et al. (2011) Expression of caspase apoptosis pathway genes mRNA in colorectal cancer and polypus. Zhejiang Da Xue Xue Bao Yi Xue Ban 40: 245-251.
37. Xu B, Zhou Z-G, Li Y, Wang L, Yang L, et al. (2008) Clinicopathological significance of caspase-8 and caspase-10 expression in rectal cancer. Oncology 74: 229-236.
38. Kim HS, Lee JW, Soung YH, Park WS, Kim SY, et al. (2003) Inactivating mutations of caspase-8 gene in colorectal carcinomas. Gastroenterology 125: 708-715.